Glatiramer acetate for multiple sclerosis.

Author: La MantiaLoredana, LovatiRoberta, MunariLuca M

Paper Details 
Original Abstract of the Article :
This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2004 , Issue 1 . Art. No.: CD004678. DOI: 10.1002/14651858.CD004678)Previous studies have shown that glatiramer acetate (Copaxone (R)), a synthetic amino acid polymer is effective in experim...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD004678.pub2

データ提供:米国国立医学図書館(NLM)

Glatiramer Acetate for Multiple Sclerosis

This study focuses on the effectiveness of glatiramer acetate, a synthetic amino acid polymer, in managing multiple sclerosis (MS). This research is a follow-up to a previous Cochrane review published in 2004. The study reviewed past research and concluded that glatiramer acetate is effective in managing MS, demonstrating a positive impact on patients’ outcomes.

Glatiramer Acetate: An Effective MS Treatment

Imagine a desert oasis where a clear spring provides relief from thirst. Glatiramer acetate serves as a similar source of relief for individuals with MS. The study indicates that glatiramer acetate is effective in treating MS, offering a potential path toward improved quality of life for those living with the disease.

Hope for MS Management

This research provides hope for individuals living with MS. The study’s findings demonstrate the efficacy of glatiramer acetate in managing MS, highlighting the importance of continued research in finding effective treatment options for this complex and debilitating disease.

Dr.Camel's Conclusion

This study provides a comprehensive review of research on glatiramer acetate, emphasizing its efficacy in treating MS. This research is crucial in navigating the challenges of MS and finding effective treatment solutions. It’s a beacon of hope in the vast desert of neurological disorders.

Date :
  1. Date Completed 2010-06-16
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

20464733

DOI: Digital Object Identifier

10.1002/14651858.CD004678.pub2

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.